Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF.

Pinar, Ibrahim Ethem; Özkocaman, Vildan; Özkalemkas, Fahir; Durgut, Himmet; Dakiki, Bahar; Ersal, Tuba; Gürsoy, Vildan; Yalçin, Cumali; Orhan, Bedrettin; Candar, Ömer; Ali, Ridvan

Pinar, Ibrahim Ethem; Özkocaman, Vildan; Özkalemkas, Fahir; Durgut, Himmet; Dakiki, Bahar; Ersal, Tuba; Gürsoy, Vildan; Yalçin, Cumali; Orhan, Bedrettin; Candar, Ömer; Ali, Ridvan.

Afiliação

Pinar IE; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Özkocaman V; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Özkalemkas F; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Durgut H; Republic of Turkey Ministry of Health, Turkish Stem Cell Coordination Center, Ankara, Turkey.
Dakiki B; Department of Internal Medicine, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Ersal T; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Gürsoy V; Department of Internal Medicine, Division of Hematology, Bursa City Hospital, Bursa, Turkey.
Yalçin C; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Orhan B; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Candar Ö; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Ali R; Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.

J Clin Apher ; 37(5): 430-437, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35689647

Assuntos

Medicamentos Biossimilares; Fator Estimulador de Colônias de Granulócitos; Antígenos CD34/metabolismo; Filgrastim; Fator Estimulador de Colônias de Granulócitos/uso terapêutico; Mobilização de Células-Tronco Hematopoéticas/métodos; Células-Tronco Hematopoéticas; Humanos; Proteínas Recombinantes; Estudos Retrospectivos; Turquia

Palavras-chave

biosimilar G-CSF; filgrastim; single-dose; split-dose; unrelated hematopoietic stem cell donors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Medicamentos Biossimilares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google